Murine studies suggest that adiponectin plays a mediating role in at least some of these obesity-related complications, and although less clearly established in humans, this suggests that understanding the pathophysiology of adiponectin may uncover novel therapeutic targets in major, highly prevalent human disease.[6], [7]. Here, ADIPOQ is linked to obesity due to melanocortin 4 receptor deficiency.